JVM: 1-(4-{5-[(piperidin-4-yl)methoxy]-3-[4-(1H-pyrazol-4-yl)phenyl]pyrazin-2-yl}phenyl)methanamine
JVM is a Ligand Of Interest in 6MO2 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6MO2_JVM_B_1201 | 6% | 4% | 0.352 | 0.795 | 3.29 | 2.52 | 18 | 13 | 2 | 0 | 100% | 1 |
| 6MO2_JVM_A_1201 | 4% | 5% | 0.373 | 0.76 | 3 | 2.33 | 19 | 21 | 3 | 0 | 100% | 1 |
